AP NEWS

Global Insulin Pens Market Report 2019-2023 Featuring Major Players - BD, Eli Lilly, Sanofi, and Novo Nordisk - ResearchAndMarkets.com

December 20, 2018

DUBLIN--(BUSINESS WIRE)--Dec 20, 2018--The “Global Insulin Pens Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The insulin pens market will register a CAGR of close to 9% by 2023.

The increasing focus on development of smart insulin pens for type 2 diabetes is likely to drive growth in the market. Companies are striving to grow in the market by incorporating advanced technologies into their products and services.

Market Overview

Growing incidence of diabetes have increased the demand for insulin pens in the market. Product recalls pose as a biggest threat to the market. Regulatory bodies and companies recalling products can impact the sales and a company’s brand image.

Competitive Landscape

The market appears to be concentrated and with the presence of few companies including BD and Eli Lilly, the competitive environment is quite intense. Factors such as the increasing focus on development of smart insulin pens and the incidences of diabetes, will provide considerable growth opportunities to insulin pens manufactures.

BD, Eli Lilly, Sanofi, and Novo Nordisk are some of the major companies covered in this report. With the presence of a considerable number of companies, this market appears to be concentrated.

Report Summary:

According to the report, one of the major drivers for this market is the growing incidence of diabetes. The latest trend gaining momentum in the market is the increasing focus on development of smart insulin pens for type 2 diabetes. Further, the report states that one of the major factors hindering the increasing product recalls.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 04: MARKET SIZING

Market sizing 2018 Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

Comparison by product Reusable insulin pens Disposable insulin pens Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation Geographic comparison Key leading countries Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

Rising strategic partnerships to boost sales of insulin pens Increasing focus on smart insulin pens Growing presence of diabetes specialty centers

PART 12: VENDOR LANDSCAPE

Landscape disruption Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors BD Eli Lilly Novo Nordisk Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/g3r8tr/global_insulin?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181220005403/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diabetes Devices ,Endocrine and Metabolic Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: DIABETES PHARMACEUTICAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/20/2018 08:31 AM/DISC: 12/20/2018 08:32 AM

http://www.businesswire.com/news/home/20181220005403/en

AP RADIO
Update hourly